版本:
中国

高管: 石藥集團有限公司 (1093.HK)

1093.HK ( 香港证券交易所 )

13.28HKD
19 Jul 2019
涨跌 (%)

HK$-0.06 (-0.45%)
收盘
HK$13.34
开盘
HK$13.40
当日最高
HK$13.58
当日最低
HK$13.24
成交量
29,729,828
平均成交量
32,486,130
52 周最高
HK$22.65
52 周最低
HK$9.90

Cai, Dongchen 

简历

Mr. Cai Dongchen is Executive Chairman of the Board, Chief Executive Officer of the Company. Mr. Cai is also the chairman of the Nomination Committee of the Company and a director of certain subsidiaries of the Group. Mr. Cai holds a MBA degree from Nankai University and has extensive technical and management experience in the pharmaceutical industry. Mr. Cai is a substantial shareholder of the Company within the meaning of Part XV of the Securities and Futures Ordinance (“SFO”). Mr. Cai is also a director of True Ally Holdings Limited and Massive Giant Group Limited, both are substantial shareholders of the Company within the meaning of Part XV of the SFO.

基础薪酬

薪酬, HKD 13,362,000
限制性股票奖励, HKD --
长期激励计划, HKD --
其他, HKD 443,000
年薪, HKD 13,805,000

期权薪酬

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
姓名 年薪

Cai Dongchen

13,805,000

Zhang Cuilong

4,326,000

Chak Kin Man

5,269,000

Li Chunlei

4,783,000

Lu Hua

4,205,000

Pan Weidong

4,387,000
更新时间  2018年 12月 31日 星期一 08:00 BJT